Expanded availability gives more growers access to Credenz smart genetics across all maturity groups
RESEARCH TRIANGLE PARK, N.C. (September 1, 2015)
– For the 2016 growing season, Bayer CropScience is expanding the Credenz®
soybean seed brand nationally, with offerings in most of the U.S. soybean production regions, providing growers more choices for complete weed management and competitive yield performance. Credenz offers LibertyLink®
and glyphosate-tolerant traits in more than 55 high-performing varieties suited to local growing conditions and tailored to address growers’ individual needs, now in expanded maturity groups 0 through 7.
Piloted last year, Credenz is the first global soybean seed brand from Bayer CropScience. This next-generation soybean offers integrated smart genetics, traits and varieties to deliver new choices for complete weed management and competitive yield performance. Credenz soybeans are bred to thrive in diverse field types and are available with the LibertyLink®
trait, which combines high-performing genetics with the power of Liberty®
herbicide for excellent control of even the toughest to control weeds. The seed also features packages with defensive traits for tolerance to frogeye leaf spot, Sudden Death Syndrome, southern stem canker, Phytophthora root rot, southern root-knot nematode, iron chlorosis, chloride sensitivity, Sclerotinia white mold, brown stem rot and soybean cyst nematode.
“Credenz is now available for soybean growers on a national scale, with characteristics to perform in a variety of soil types and relative maturities, offering growers a customizable platform tailored to meet a wide range of individual production preferences,” said Allen Gent, Director, U.S. Soybean Seed Operations, Bayer CropScience. “Coupled with a robust portfolio of crop protection and SeedGrowth products from Bayer, Credenz can help growers maximize today’s high-performance soybean yield potential.”
Credenz is backed by scientific expertise, a full portfolio of soybean solutions, and a pipeline of innovations from Bayer CropScience to support soybean growers now and in the future. The company is currently working on research projects in seed breeding, traits and crop protection to help growers better address issues including weeds, nematodes, pests, diseases and overall crop efficiency. As part of that mission, Bayer CropScience is working with partners to deliver the best biotechnologies science has to offer, including several new soybean traits over the next five years and beyond. Two herbicide-tolerant traits coming soon are Balance® GT
*, which provides tolerance to glyphosate and Balance®
Bean** herbicide, and Balance GT/LibertyLink, which provides tolerance to glyphosate, Balance Bean and Liberty herbicide. All together, these ongoing innovations allow Bayer to deliver the best seed with the right characteristics and superior protection to meet growers’ needs for healthy, high-performing soybeans.
While Credenz may be a relative newcomer in the market, Bayer CropScience has been committed to agricultural innovation and soybean productivity for more than a century. A 150-year investment in research, people and infrastructure has positioned Bayer CropScience as a leading technology provider in agriculture. Today, the company remains at the forefront of new product development. Molecular breeding and trait integration scientists work hand-in-hand with agronomists, entomologists and plant pathologists to ensure the right seed is created with the right traits and characteristics to meet growers’ need for healthy, high-yielding soybeans.
“Bayer CropScience has a long history in the seeds business, including a proven track record in cotton, vegetable and canola seed, along with trait solutions across multiple crops,” concluded Gent. “That foundation drives our approach to Credenz. We’re proud to have our science at work for even more growers across the U.S. for next growing season.”
*Developed with MS Technologies. Balance GT has not received all needed regulatory approvals.
**Balance Bean is not registered for sale or use in the United States.
Bayer CropScience Twitter Page:
Bayer CropScience Blog:
Bayer CropScience is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer CropScience representative, or visit Bayer CropScience online at www.bayercropscience.us.
Visit the Bayer Connect - Social Hub
for all Bayer CropScience social media, recent news, blog posts, videos and more. Bayer, the Bayer Cross, LibertyLink, Liberty, Balance®
, and Credenz are registered trademarks of Bayer.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 9,494 million (2014) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 23,100 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com
Bayer CropScience Media Hotline, 1-862-404-5118, or
Tel: (919) 549-5395
Shani St. John
Tel: (404) 995-4500
Find more information at http://www.bayercropscience.us
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.